Early Access to Prostate Cancer Drug on NHS

Screen Shot 2016-02-05 at 15.17.24

Patients with prostate cancer in England will now have early access to a drug that can delay the need for chemotherapy.

The National Institute for Health and Care Excellence (NICE) has approved the drug abiraterone for men with advanced prostate cancer, who have not yet had chemotherapy.

The drug – developed by UK scientists – can delay the disease’s progression, help to prolong life, and provide a better quality of like with less fatigue and pain. It has been available across the UK for men after chemotherapy since 2012.

Read the full article at Cancer Research UK

http://www.cancerresearchuk.org/about-us/cancer-news/news-report/2016-03-21-prostate-cancer-drug-approved-for-routine-use-before-chemotherapy

 


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s